Amniocentesis Needle Market - By Product Type (100 to 150 mm, Smaller Than 100 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Amnioinfusion, Cordocentesis), End-use (Hospital, Diagnostics Center, Clinic) – Global Forecast, 2024 – 2032

Amniocentesis Needle Market Size

Amniocentesis Needle Market size was valued at around USD 177 million in 2023 and is anticipated to register a CAGR of 4.9% between 2024 and 2032. Amniocentesis needle refers to a specialized medical instrument used in the amniocentesis procedure, which is a diagnostic test performed during pregnancy. The needle is designed for the purpose of extracting a small amount of amniotic fluid from the amniotic sac surrounding a developing fetus.
 

This robust market growth can be attributed to various factors, including ongoing technological advancements in amniocentesis needles, rising prevalence of chronic diseases among expectant mothers, growing awareness and education regarding amniocentesis, the continual growth of healthcare expenditure, and the increasing preference for ultrasound needles, which accounted for USD 272.5 million in 2022, among other contributing factors.
 

Furthermore, anticipated market expansion is attributed to multiple factors, including the, raising maternal age and increasing rates of prenatal screening. For instance, in 2022, according to BMC Pregnancy and Childbirth in pregnancies of advanced maternal age (AMA), invasive diagnostic testing was performed in 87.22% cases.
 

Amniocentesis Needle Market Trends

Market expansion is anticipated to be propelled by the technological advancements which collectively contribute to improving the quality of amniocentesis needle, making them more patient-friendly, and developing the needles with finer gauges and specialized tips to minimize tissue trauma. Recently introduced incorporated technologies such as, microfluidic technologies, advanced imaging technologies, steerable needles,  biocompatible materials. These contributes to improve the safety, accuracy, and overall effectiveness of amniocentesis procedures.
 

• The shift from static to dynamic variable monitoring and the advancement of minimally invasive technological approaches are projected to foster market growth in the forecast period.
   
• Furthermore, the escalating preference for amniocentesis needle has also stimulated increased focus on research and development, aiming to improve safety, accuracy, and accessibility, the endeavors in amniocentesis strive to empower expectant parents with comprehensive information about fetal health and genetic conditions.
   

Amniocentesis Needle Market Analysis

Based on product type, the market is segmented into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The amniocentesis needle type 100 to 150 mm is estimated to account for USD 94.6 million in 2023.
 

• Amniocentesis needles play a crucial role by employing suitable lengths of needle, thus minimizing the likelihood of procedural complications like tissue damage or insufficient sample collection.
   
• Furthermore, needles in the range of 100 to 150 mm strike a balance between being long enough to reach the amniotic sac safely and short enough to minimize the risk of complications such as uterine perforation.
   
• Moreover, the length of these needles allows for efficient collection of an adequate volume of amniotic fluid, ensuring accurate diagnostic testing without the need for multiple attempts.

The amniocentesis needle market by procedure is categorized into amniocentesis procedures, amnioreduction procedures, fetal blood transfusions, amnioinfusion procedures, and cordocentesis procedures. The amniocentesis procedures accounted for around USD 61.6 million revenue size in 2023.
 

• Amniocentesis facilitates the retrieval of amniotic fluid, rich in fetal cells and DNA, enabling precise assessment of the fetus's health and genetic composition, thereby facilitating the accurate diagnosis of a diverse array of genetic disorders and chromosomal abnormalities.
   
• Furthermore, by detecting genetic conditions such as down syndrome, cystic fibrosis, and neural tube defects early in pregnancy, amniocentesis enables expectant parents to make informed decisions about their pregnancy and potential medical interventions.
   
• Moreover, the amniocentesis procedure provides significant advantages in terms of accurate prenatal diagnosis, early detection and intervention, personalized risk assessment, reduction of uncertainty, improved prenatal care.

North America amniocentesis needle market accounted for USD 71.8 million revenue in 2023 and is predicted to witness substantial market growth.
 

• The large market share is correlated to a sophisticated healthcare systems with access to advanced medical technologies, facilitating widespread availability and utilization of amniocentesis procedures and related equipment like needles.
   
• The trend of delaying childbirth and an increase in maternal age contribute to a higher risk of chromosomal abnormalities in fetuses. Older mothers are more likely to undergo prenatal screening, including amniocentesis, to assess fetal health, leading to increased demand for amniocentesis needles.
   

Amniocentesis Needle Market Share

The amniocentesis needle industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players Becton, Dickinson, and Company, CooperSurgical, Inc, Rocket Medical plc, among others have a notable presence in the market.
 

Amniocentesis Needle Market Companies

Some of the eminent market participants operating in the amniocentesis needle industry include:   

• Argon Medical Devices Inc.
• AngioDynamics Inc.
• Becton Dickinson and Company
• Biopsybell Srl
• Cook Medical 
• CooperSurgical, Inc. 
• Integra LifeSciences Corporation
• Laboratoire CCD
• Medline Industries, Inc.
• Medtronic plc 
• RI.MOS. Srl   
• Rocket Medical plc.  
• Smiths Group plc
• Teleflex Incorporated
• Terumo Corporation 
   

Amniocentesis Needle Industry News:

• In February 2022, CooperSurgical completed the acquisition of Cook Medical’s reproductive health portfolio for a significant sum of USD 875 million. The acquired portfolio includes various medical devices tailored for fertility, obstetrics, gynecology, and in vitro fertilization (IVF). This strategic move has allowed CooperSurgical to broaden its product offerings and enhance its portfolio within the reproductive health sector.
   
• In March 2021, Becton, Dickinson, and Company introduced the BD Chorionic Villus Sampling (CVS) System, featuring an innovative ergonomic handle designed to minimize hand fatigue and improve accuracy during amniocentesis procedures. This advancement marked a significant step forward in enhancing the safety and efficiency of prenatal diagnostic techniques.
   

The amniocentesis needle market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• 100 to 150 mm                
• Smaller than 100 mm                 
• Larger than 150 mm

Market, By Procedure

• Amniocentesis procedures 
• Amnioreduction procedures            
• Fetal blood transfusions                   
• Amnioinfusion procedures               
• Cordocentesis procedures                         

Market, By End-use

• Hospitals                                                                     
• Diagnostics centers                                                              
• Clinics                                                             
• Other end-users                                                       

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa